Apps by KENNETH SCOTT GUBER
CoroCompass CV Risk Prevention app icon

Medical

CoroCompass CV Risk Prevention

KENNETH SCOTT GUBER

Free download In-app purchases unconfirmed
Open on Apple

About this app

CoroCompass is the essential digital assistant for cardiology prevention, designed for clinicians helping patients navigate risk stratification and lipid management. Key Features: • Advanced Risk Stratification: Calculate 10-year ASCVD risk, augmented with integrated guideline-based "risk enhancers". • Coronary Calcium (CAC) Scoring: Input Agatston scores and demographics to instantly visualize MESA percentiles and risk categories. • Lipid Management: Built-in Friedewald LDL calculator and guideline-directed goal setting. • Clinical Decision Support: Generate instant, text-based clinical summaries with specific recommendations for statin therapy and aspirin therapy based on the latest ACC/AHA prevention and cholesterol guidelines. • Reference Library: Quick access to statin therapy intensity tables and key guideline summaries and hyperlinks. Designed for Speed and Privacy: • No login required. • All calculations happen locally on your device (no need for internet connection). • No patient data is ever stored or transmitted. Streamline your primary prevention workflow with this suite of guideline-based tools! IMPORTANT MEDICAL DISCLAIMER: This app is designed for educational and clinical decision support purposes only. It is not intended to provide a medical diagnosis or replace professional medical advice, diagnosis, or treatment. The calculations and recommendations provided are based on established clinical guidelines but should not be used as the sole basis for patient care. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this application.

Latest release

What’s New

Version 1.4 Mar 27, 2026

CoroCompass has been updated to incorporate the latest clinical evidence and guideline-directed medical therapy. • 2026 Dyslipidemia Guidelines: Full integration of the 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia. Access updated risk assessment tools and evidence-based statin therapy recommendations. • Improved Compliance: We have updated our User Agreement to better reflect our commitment to data privacy and professional use. • Bug Fixes: Performance improvements and minor UI refinements to ensure a smoother clinical experience.

Audience growth

Ratings growth

Steady
7-day gain +0
Ratings / day 0.0
30-day gain +0
US rating-count history
0 ratings
0 Aug 23, 2026 · 0 ratings Aug 23, 2026

Baseline captured. Growth appears after the crawler observes a changed rating count.

Momentum comes from crawler snapshots for the tracked storefront. “Viral growth signal” means unusually fast recent rating gains; it is an indicator, not download data.

Price tracking

Price intelligence

1 captured event
Current Free
Historical low Free
Paid → free
Price history
Current Free
Free Aug 23, 2026 · Free Aug 23, 2026

First snapshot captured. The trend line starts after the next crawler price observation.

  1. First observed Aug 23, 2026 · 6:09 AM Free

Screenshots

CoroCompass CV Risk Prevention iPhone screenshotCoroCompass CV Risk Prevention iPhone screenshotCoroCompass CV Risk Prevention iPhone screenshotCoroCompass CV Risk Prevention iPhone screenshotCoroCompass CV Risk Prevention iPhone screenshotCoroCompass CV Risk Prevention iPhone screenshotCoroCompass CV Risk Prevention iPhone screenshotCoroCompass CV Risk Prevention iPhone screenshot CoroCompass CV Risk Prevention iPad screenshotCoroCompass CV Risk Prevention iPad screenshotCoroCompass CV Risk Prevention iPad screenshotCoroCompass CV Risk Prevention iPad screenshotCoroCompass CV Risk Prevention iPad screenshotCoroCompass CV Risk Prevention iPad screenshotCoroCompass CV Risk Prevention iPad screenshot